Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enarodustat Initial Doses in Non-Dialysis CKD Anemia
NCT07079579Phase 4Not yet recruiting
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Aug 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enarodustat in anemia of chronic kidney disease (CKD-A), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
enarodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT07079579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07079579.